Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003
Paraplegia After Ligation of Esophageal Varices
Neurol 60:879, Debette,S.,et al, 2003
Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003
Surgical Induction of Zoster in a Contralateral Homologous Dermatomal Distribution
Arch Neurol 60:616-617, Gilden,D.H. &Katz,R.I., 2003
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
Validation of Diagnositc Magnetic Resonance Imaging Criteria for Multiple Sclerosis and Response to Interferon B1a
Ann Neurol 53:718-724, Barkhof,F.,et al, 2003
Acupuncture in Clinical Neurology
The Neurologist 9:137-148, Rabinstein,A.A. &Shulman,L.M., 2003
Neurologic Injury After Endovascular Stent-Graft and Bilateral Internal Iliac Artery Embolization for Infrarenal Abdominal Aortic Aneurysm
J Vasc Interv Radiol 12:761-763, Kwok,P.C.-H.,et al, 2003
Paralysis of the Femoral Nerve Following Totally Extraperitoneal Laparscopic Inguinal Hernia Repair
Surg Endosc 17:1157, Lange,B.,et al, 2003
Spinal Cord Biopsy: A Review of 38 Cases
Neurosurgery 52:806-816, Cohen-Gadol,A.A.,et al, 2003
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002
Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002
Management of Acute Optic Neuritis
Lancet 360:1953-1962, Hickman,S.J.,et al, 2002
Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002
Euthanasia and Physician-Assisted Suicide Among Patients with Amyotrophic Lateral Sclerosis in the Netherlands
NEJM 346:1638-1644, Veldink,J.H.,et al, 2002
Efficacy and Safety of Modafinil (Provigil) for the Treatment of Fatigue in Multiple Sclerosis: A Two Centre Phase 2 Study
JNNP 72:179-183,150, Rammohan,K.W.,et al, 2002
Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002
Brain Damage After Coronary Artery Bypass Grafting
Arch Neurol 59:1090-1095,1074, Bendszus,M.,et al, 2002
Sporadic Creutzfeldt-Jakob Disease and Surgery
Neurol 59:543-548, Ward,H.J.T.,et al, 2002
Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002
Encephalopathy and Stroke after Coronary Artery Bypass Grafting
Arch Neurol 59:1422-1428, McKhann,G.M.,et al, 2002
Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002
Cardiac Adverse Effects Associated with Mitoxantrone (Novantrone) Therapy in Patients with MS
Neurol 59:909-913, Ghalie,R.G.,et al, 2002
Aggressive Behavior Induced by Intraoperative Stimulation in the Triangle of Sano
Neurol 59:1425-1427, Bejjani,B.P.,et al, 2002
Mania Following Deep Brain Stimulation for Parkinson's Disease
Neurol 59:1421-1424, Kulisevsky,J.,et al, 2002
High-Dose Thiopental in the Treatment of Refractory Status Epilepticus in Intensive Care Unit
Neurol 59:1249-1251, Parviainen,I.,et al, 2002
A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002
Refractory Neurosarcoidosis Responding to Infliximab
Neurol 59:1660-1661, Pettersen,J.A.,et al, 2002
Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002
Hospital and Surgeon Determinants of Carotid Endarterectomy Outcomes
Arch Neurol 59:1877-1881,1866, Feasby,T.E.,et al, 2002
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Refractory Status Epilepticus
Arch Neurol 59:205-210,188, Mayer,S.A.,et al, 2002
Postoperative Hyperthermia is Associated With Cognitive Dysfunction After Coronary Artery Bypass Graft Surgery
Stroke 33:537-541, Grocott,H.P.,et al, 2002
Pituitary Apoplexy Presenting as Postoperative Stupor
Neurol 58:500-501, Tang-Wai,D.F. &Wijdicks,E.F.M., 2002
An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002
Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002
Plasma Exchange for Severe Attacks of CNS: Demyelination: Predictors of Response
Neurol 58:143-146, Keegan,M.,et al, 2002
Recent Developments in Neurology
BMJ 324:656-660, Wiebe,S.,&Nicolle,M.W., 2002
Multiple Sclerosis
Lancet 359:1221-1231, Compston,A. &Coles,A., 2002
Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS
Neurol 58:1404-1407,1323, Killestein,J.,et al, 2002
Outcome of and Prognostic Factors for Herpes Simplex Encephalitis in Adult Patients: Results of a Multicenter Study
Clin Inf Dis 35:254-260, Raschillas, F.,et al, 2002
Infective Endocarditis Resulting from CardioSEAL Closure of a Patent Foramen Ovale
Catheter Cardiovasc Interv 55:217-220, Goldstein,J.A.,et al, 2002
Persistent Cognitive Impairment Following Surgical Treatment of Cushings Syndrome
Psychoneuroendocrinology 27:367-383, Forget,H.,et al, 2002
Obturator Neuropathy: Causes and Outcome
Muscle Nerve 25:605-607, Sorenson,E.,et al, 2002
Fat embolism syndrome and elective knee arthroplasty
Can J Anesth 49:19-23, Jenkins, K.,et al, 2002
Clinical Spectrum of Posterior Ischemic Optic Neuropathy
Am J Ophthalmol 132:743-750, Sadda,S.R.,et al, 2001
Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001
The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001